Thomas O Carpenter
23PUBLICATIONS
85CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (23)
Sort by Publication Date:
|Apr 04, 2026
Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program.Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli
|Mar 30, 2026
Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.Seiji Fukumoto, Dieter Haffner, Erik A Imel
|Feb 02, 2026
Bone Age Delay in X-linked Hypophosphatemia.Julio Soto, Rucha Anant Patki, Lauren J Ehrlich
|Nov 18, 2025
The prevalence of ENPP1 deficiency in humans with Ossification of the Posterior Longitudinal Ligament and the preclinical efficacy of ENPP1 enzyme therapy in murine Ossification of the Posterior Longitudinal Ligament.Shivani Srivastava, Hajime Kato, Simon von Kroge
|Nov 04, 2025
Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need.Suma Uday, M Zulf Mughal, Hamilton Cassinelli
|Jul 12, 2025
3D-DXA reveals significant effects of burosumab on trabecular and cortical skeletal envelopes in symptomatic adults with X-linked hypophosphatemia.Rucha Patki, Thomas Carpenter, Keerti Murari
Pageof 4
Frequent Collaborators
10 joint publications
Erik A Imel
8 joint publications
Leanne M Ward
8 joint publications
Pablo Florenzano
7 joint publications
Maria Luisa Brandi
7 joint publications
Suzanne M Jan de Beur
6 joint publications
Natasha M Appelman-Dijkstra
6 joint publications
Farah Alsarraf
6 joint publications
Rachel K Crowley
6 joint publications
Dalal S Ali
6 joint publications
Salma Hussein
